Nuveen Asset Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.93M | Buy |
125,668
+378
| +0.3% | +$8.8K | ﹤0.01% | 2225 |
|
|
2024
Q3 | $3.68M | Buy |
125,290
+8,150
| +7% | +$240K | ﹤0.01% | 2128 |
|
|
2024
Q2 | $2.75M | Buy |
+117,140
| New | +$2.75M | ﹤0.01% | 2223 |
|
|
2022
Q2 | – | Sell |
-6,765
| Closed | -$425K | – | 3390 |
|
|
2022
Q1 | $425K | Buy |
6,765
+12
| +0.2% | +$754 | ﹤0.01% | 3058 |
|
|
2021
Q4 | $653K | Sell |
6,753
-433
| -6% | -$41.9K | ﹤0.01% | 2998 |
|
|
2021
Q3 | $1.34M | Sell |
7,186
-185
| -3% | -$34.5K | ﹤0.01% | 2859 |
|
|
2021
Q2 | $1.28M | Buy |
7,371
+1,056
| +17% | +$184K | ﹤0.01% | 2914 |
|
|
2021
Q1 | $1.25M | Sell |
6,315
-303
| -5% | -$60K | ﹤0.01% | 2819 |
|
|
2020
Q4 | $1.3M | Sell |
6,618
-34
| -0.5% | -$6.69K | ﹤0.01% | 2704 |
|
|
2020
Q3 | $1.18M | Sell |
6,652
-1,684
| -20% | -$298K | ﹤0.01% | 2617 |
|
|
2020
Q2 | $1.93M | Buy |
8,336
+4,792
| +135% | +$1.11M | ﹤0.01% | 2353 |
|
|
2020
Q1 | $413K | Sell |
3,544
-14
| -0.4% | -$1.63K | ﹤0.01% | 2834 |
|
|
2019
Q4 | $680K | Sell |
3,558
-1,963
| -36% | -$375K | ﹤0.01% | 2821 |
|
|
2019
Q3 | $1.06M | Sell |
5,521
-35
| -0.6% | -$6.73K | ﹤0.01% | 2678 |
|
|
2019
Q2 | $951K | Buy |
+5,556
| New | +$951K | ﹤0.01% | 2762 |
|